Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
2024 · BMC Cancer · 11 citations
https://doi.org/10.1186/s12885-024-12151-7